Tag: Lupus
ACR: Low-Dose Hydroxychloroquine Tied to More Hospitalizations for Lupus Flares
Both weight-based and non-weight-based low-dose HCQ associated with increased hospitalizations for SLE
Sleep Deprivation May Increase Risk for Systemic Lupus in Women
Additive interactions between low sleep duration and depression or bodily pain may contribute to risk for systemic lupus erythematosus
Reduction in Swollen, Tender Joints Greater With Litifilimab in Lupus
Most secondary end points did not support the results of the analysis for the primary end point
Breakthrough Infections in Lupus Patients Down With COVID Booster
Sixty-four percent of those with breakthrough COVID-19 had received booster compared with 82 percent of those without breakthrough infection
Normal-Looking Skin Involved in Cutaneous Lupus Erythematosus
Normal-appearing skin is type I interferon-rich environment; interferon-induced gene expression changes seen in all major skin type cells
Racial Disparities Seen in Adverse Renal Outcomes for Pediatric Lupus
Proportion of admissions with adverse renal outcomes decreased from 2006 to 2019, but racial disparities persisted
ACR: Lupus Patients Can Have Low Immune Response to COVID-19 Vaccines
However, overall disease activity does not appear to change after vaccination
ACR: COVID-19 Vaccine Not Tied to Severe Rheumatic Disease Flares
Seropositivity lags after vaccination in those with rheumatic diseases but improves after second dose
Belimumab Promising in Combination Therapy for Refractory Lupus
Lower serum IgG anti-dsDNA antibody levels seen at 52 weeks with belimumab rather than placebo given after rituximab